Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Ferric Carboxymaltose

Research Leaders

5 sponsors active, led by Herzzentrum Bremen

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Withdrawn1
Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Ferric Carboxymaltose2
  • Subsequent Fcm1
  • Subsequent Exercise Training1
  • Initial Fcm1
  • Ferric Carboxymaltose Fcm1

Active Sponsors

  • Herzzentrum Bremen1
  • Marmara University Pendik Training and Research Hospital1
  • Aristotle University Of Thessaloniki1
  • Ordu University1
  • Xuanwu Hospital, Beijing1

Top Investigators

Related Conditions

  • Heart Failure With Reduced Ejection Fraction2
  • Parenteral Iron Therapy1
  • Arrhythmias Cardiac1
  • Exercise Training1
  • Methemoglobinemia1

Activity Timeline